DENVER, CO – May 21, 2025 – Ibogaine By David Dardashti, will be hosting a booth at the upcoming Psychedelic Science 2025 conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS). The conference, a premier global gathering for psychedelic research, medicine, policy, and culture, will take place from June 16-20, 2025, at the Colorado Convention ...
Ibogaine, a psychoactive compound extracted from the African Tabernanthe iboga plant, has gained attention for its potential to disrupt addictive …
Ibogaine by David Dardashti, a leading provider of ibogaine treatment for addiction, today announced a groundbreaking initiative that combines cutting-edge therapy with transformative travel experiences. The company is now offering clients the opportunity to participate in fully-funded therapeutic adventures to breathtaking destinations in Mexico, including Isla Mujeres, Cozumel, ...
Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine’s therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate genetic mechanisms underlying neurological disorders, including Parkinson’s disease. This research, spearheaded by Associate Professor Masahito Yoshihara and colleagues, provides compelling evidence that could significantly impact the ...